Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001943462-24-000010·Dellora Investments LP
Schedule 13G ownership disclosure
Palvella Therapeutics Inc
Common Stock, $0.001 par value · CUSIP: 697947109
Event date: 2024-12-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Dellora Investments Master Fund LP
Shares: 123,034.00 · Class: 1.1%
- Dellora Investments LP
Shares: 141,079.00 · Class: 1.3%
- Kevin Pyun
Shares: 141,079.00 · Class: 1.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001943462-24-000010
- Form type
- SCHEDULE 13G/A
- Filer
- Dellora Investments LP
- CIK
- CIK 1943462
- Filed
- Dec 17, 2024
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13G beneficial ownership